Diazoxide - Isotope Labelled Standards
References
FAQ's
References
- Topliss, John G.; Sperber, Nathan; Rubin, Alan A., Method for the treatment of hypertension, Schering Corp., US2986573A, May 30, 1961
- Sadee, Wolfgang; Segal, Jack; Finn, Claude, Diazoxide urine and plasma levels in humans by stable-isotope dilution-mass fragmentography, Journal of Pharmacokinetics and Biopharmaceutics, Volume: 1, Issue: 4, Pages: 295-305, 1973
Frequently Asked Questions
What is the significance of analyzing Diazoxide impurities?
Analyzing Diazoxide impurities helps ensure the drug's quality, safety, and efficacy. It helps determine the impurity level and its potential impact on the drug's effectiveness and stability.
How are the Diazoxide impurities synthesized?
Diazoxide impurities can be synthesized through chemical reactions involving Diazoxide or its intermediates. These reactions may occur during the drug synthetic process or under specific conditions for impurity formation.
Which solvent helps in the analysis of Diazoxide impurities?
Methanol is a solvent used in analyzing many impurities in Diazoxide.
What are the temperature conditions required to store Diazoxide impurities?
Diazoxide impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.